Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.

BACKGROUND Multiple sclerosis (MS) is a prototype neuroinflammatory disorder with increasingly recognized role for neurodegeneration. Most first-line treatments cannot prevent the progression of neurodegeneration and the resultant disability. Interventions can improve symptoms of MS and might provide insights into the underlying pathology. OBJECTIVE To investigate the effect of intermittent caloric restriction on neuroimaging markers of MS. METHODS We randomized ten participants with relapsing remitting MS to either a 12-week intermittent calorie restriction (iCR) diet (n = 5) or control (n = 5). Cortical thickness and volumes were measured through FreeSurfer, cortical perfusion was measured by arterial spin labeling and neuroinflammation through diffusion basis spectrum imaging. RESULTS After 12 weeks of iCR, brain volume increased in the left superior and inferior parietal gyri (p: 0.050 and 0.049, respectively) and the banks of the superior temporal sulcus (p: 0.01). Similarly in the iCR group, cortical thickness improved in the bilateral medial orbitofrontal gyri (p: 0.04 and 0.05 in right and left, respectively), the left superior temporal gyrus (p: 0.03), and the frontal pole (p: 0.008) among others. Cerebral perfusion decreased in the bilateral fusiform gyri (p: 0.047 and 0.02 in right and left, respectively) and increased in the bilateral deep anterior white matter (p: 0.03 and 0.013 in right and left, respectively). Neuroinflammation, demonstrated through hindered and restricted water fractions (HF and RF), decreased in the left optic tract (HF p: 0.02), and the right extreme capsule (RF p: 0.007 and HF p: 0.003). CONCLUSION These pilot data suggest therapeutic effects of iCR in improving cortical volume and thickness and mitigating neuroinflammation in midlife adults with MS.

[1]  M. Filippi,et al.  Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis , 2022, Journal of Neurology.

[2]  F. Barkhof,et al.  Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis , 2022, Neurology.

[3]  P. Bhargava,et al.  Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis , 2022, medRxiv.

[4]  F. Zipp,et al.  Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[5]  M. Bloemendaal,et al.  The Effects of Intermittent Fasting on Brain and Cognitive Function , 2021, Nutrients.

[6]  J. Richards,et al.  Childhood obesity and multiple sclerosis: A Mendelian randomization study , 2021, Multiple sclerosis.

[7]  L. Piccio,et al.  Effects of dietary restriction on neuroinflammation in neurodegenerative diseases , 2021, The Journal of experimental medicine.

[8]  Nick C Fox,et al.  Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease , 2020, NeuroImage: Clinical.

[9]  J. Jensen,et al.  The impact of edema and fiber crossing on diffusion MRI metrics assessed in an ex vivo nerve phantom: Multi‐tensor model vs. diffusion orientation distribution function , 2020, NMR in biomedicine.

[10]  I. S. Ismail,et al.  Intermittent Fasting Enhanced the Cognitive Function in Older Adults with Mild Cognitive Impairment by Inducing Biochemical and Metabolic changes: A 3-Year Progressive Study , 2020, Nutrients.

[11]  Brian A. Gordon,et al.  Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia , 2020, NeuroImage: Clinical.

[12]  D. Ramasamy,et al.  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy controls , 2020, Neurobiology of Aging.

[13]  A. Molofsky,et al.  Astrocytes and Microglia: In Sickness and in Health , 2020, Trends in Neurosciences.

[14]  J. Petrosino,et al.  Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. , 2020, Journal of proteomics.

[15]  K. Trinkaus,et al.  Diffusion basis spectrum imaging provides insights into MS pathology , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[16]  K. Trinkaus,et al.  Diffusion basis spectrum imaging for identifying pathologies in MS subtypes , 2019, Annals of clinical and translational neurology.

[17]  V. Zachariou,et al.  Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research , 2019, Biomedicines.

[18]  A. Artemiadis,et al.  Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options , 2019, Autoimmunity Highlights.

[19]  Brian A. Gordon,et al.  Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease , 2019, NeuroImage: Clinical.

[20]  Yang Li,et al.  ASL‐MRICloud: An online tool for the processing of ASL MRI data , 2019, NMR in biomedicine.

[21]  P. Gallo,et al.  Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis , 2018, Multiple Sclerosis and Demyelinating Disorders.

[22]  Paul M. Thompson,et al.  Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3 , 2018, bioRxiv.

[23]  R. de Cabo,et al.  Comparing the Effects of Low-Protein and High-Carbohydrate Diets and Caloric Restriction on Brain Aging in Mice , 2018, Cell reports.

[24]  M. Mattson,et al.  Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. , 2018, Multiple sclerosis and related disorders.

[25]  G. Weinstock,et al.  Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. , 2018, Cell metabolism.

[26]  A. Brickman,et al.  White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes , 2018, Acta neuropathologica communications.

[27]  M. Mattson,et al.  Intermittent metabolic switching, neuroplasticity and brain health , 2018, Nature Reviews Neuroscience.

[28]  A. Traboulsee,et al.  What Have We Learned from Perfusion MRI in Multiple Sclerosis? , 2018, American Journal of Neuroradiology.

[29]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[30]  Nicholas C. Firth,et al.  Progression of regional grey matter atrophy in multiple sclerosis , 2017, bioRxiv.

[31]  Dev Mehta,et al.  Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 , 2017, Expert opinion on investigational drugs.

[32]  Sheng-Kwei Song,et al.  “A new imaging modality to non-invasively assess multiple sclerosis pathology” , 2017, Journal of Neuroimmunology.

[33]  A. Lin,et al.  Neuroimaging Biomarkers of Caloric Restriction on Brain Metabolic and Vascular Functions , 2017, Current Nutrition Reports.

[34]  Marco Prinz,et al.  The role of peripheral immune cells in the CNS in steady state and disease , 2017, Nature Neuroscience.

[35]  T. Morgan,et al.  A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.

[36]  M. Sormani,et al.  The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis , 2016, PloS one.

[37]  Pierrick Coupé,et al.  volBrain: An Online MRI Brain Volumetry System , 2015, Front. Neuroinform..

[38]  F. Sacks,et al.  MIND diet slows cognitive decline with aging , 2015, Alzheimer's & Dementia.

[39]  Liang Shen,et al.  Vitamin D deficiency is associated with increased risk of Alzheimer’s disease and dementia: evidence from meta-analysis , 2015, Nutrition Journal.

[40]  F. Barkhof,et al.  Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long‐standing multiple sclerosis , 2015, Human brain mapping.

[41]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[42]  K. Trinkaus,et al.  Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice , 2014, NMR in biomedicine.

[43]  Ludwig Kappos,et al.  Vitamin D as an early predictor of multiple sclerosis activity and progression. , 2014, JAMA neurology.

[44]  M. Filippi,et al.  Relationship between damage to the cerebellar peduncles and clinical disability in multiple sclerosis. , 2014, Radiology.

[45]  C. Koebnick,et al.  Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.

[46]  Ian R. Lanza,et al.  Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis. , 2012, Cell metabolism.

[47]  M. Gorno-Tempini,et al.  White matter atrophy in Alzheimer's disease variants , 2012, Alzheimer's & Dementia.

[48]  Massimo Filippi,et al.  Association between pathological and MRI findings in multiple sclerosis , 2012, The Lancet Neurology.

[49]  Jong M. Rho,et al.  The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders , 2012, Front. Pharmacol..

[50]  L. Fratiglioni,et al.  Midlife overweight and obesity increase late-life dementia risk , 2011, Neurology.

[51]  L. Piccio,et al.  Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis , 2008, Journal of leukocyte biology.

[52]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[53]  David H. Miller,et al.  Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.

[54]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[55]  R. de Cabo,et al.  Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[56]  W. Brück Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis , 2005, Journal of Neurology.

[57]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[58]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[59]  D. Ingram,et al.  Aging and Caloric Restriction in Nonhuman Primates , 2001, Annals of the New York Academy of Sciences.